| 000 | 01414 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511191055.0 | ||
| 264 | 0 | _c19921015 | |
| 008 | 199210s 0 0 eng d | ||
| 022 | _a0031-7012 | ||
| 024 | 7 |
_a10.1159/000138982 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitzen, J M | |
| 245 | 0 | 0 |
_aPotassium channel activators cromakalim and celikalim (WAY-120,491) fail to decrease myocardial infarct size in the anesthetized canine. _h[electronic resource] |
| 260 |
_bPharmacology _c1992 |
||
| 300 |
_a71-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Vessels _xphysiopathology |
| 650 | 0 | 4 | _aCromakalim |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
| 700 | 1 | _aMcCallum, J D | |
| 700 | 1 | _aHarvey, C | |
| 700 | 1 | _aMorin, M E | |
| 700 | 1 | _aOshiro, G T | |
| 700 | 1 | _aColatsky, T J | |
| 773 | 0 |
_tPharmacology _gvol. 45 _gno. 2 _gp. 71-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000138982 _zAvailable from publisher's website |
| 999 |
_c1529700 _d1529700 |
||